Back to Search Start Over

134P Safety and efficacy of multi-target TKI combined with nivolumab in checkpoint inhibitor-refractory advanced NSCLC patients: A prospective, single arm, two stage study

Authors :
B. Han
B. Zhang
H. Zhong
C. Shi
Z. Gao
R. Zhong
A. Gu
T. Chu
H. Wang
L. Xiong
W. Zhang
X. Zhang
B. Yan
J. Teng
W. Wang
H. Bai
R. Qiao
L. Cheng
Y. Kuang
Source :
Immuno-Oncology and Technology. 16:100246
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Immunology and Allergy

Details

ISSN :
25900188
Volume :
16
Database :
OpenAIRE
Journal :
Immuno-Oncology and Technology
Accession number :
edsair.doi...........6d377083307750ce3779ff05a37af617
Full Text :
https://doi.org/10.1016/j.iotech.2022.100246
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details